RecruitingNCT06319872
Disulfiram treatment and vision in people with retinal degeneration
About this title
Read the official source — NCT06319872Medication studyAges 18+United StatesAddiction
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- RochesterSee all locations and recruitment
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: May 19, 2025
- Recruitment status
- Recruiting
- Enrollment listed in the registry
- 15
- Sponsor
- University of Rochester
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Drug
- Study phase
- Phase 1Usually an early study focused on safety, tolerability, dosage, and side effects.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT06319872
- Official title
Show the full official title
The Effects of Disulfiram on Visual Acuity in Patients With Retinal Degeneration
Recruitment & locations
Currently recruitingA study may be recruiting, but some locations may no longer be accepting participants. Confirm availability with the research team.
Rochester
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is University of Rochester, a university.
Does this study involve medication?
Yes. The study involves medication, including Oral disulfiram.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as recruiting.
